Glucocorticoid resistance in humans—associated with recurring lifetime vulnerability to major depressive disorder (MDD) and other brain diseases—is potentially associated with higher induced levels of FKBP5 (28,29). The gene discussed is FKBP5; the disease is glucocorticoid resistance.